Health
Development of an inactivated vaccine candidate for SARS-CoV-2 – Science Magazine
Global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to an urgent race to develop a vaccine. Gao et al. report preclinical results of an early vaccine candidate called PiCoVacc, which protected rhesus macaque monkeys against S…
Abstract
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in an unprecedented public health crisis. Because of the…
-
Business12 hours agoSilver reaches a 14-year high. Will it outperform the gold price this year?
-
Business17 hours agoWhere I’d invest $5,000 into ASX dividend shares right now
-
Business14 hours ago$20,000 in savings? Here’s how to target $1,000 of passive income each month
-
Noosa News14 hours agoSunraysia wine grape grower’s chemical-free approach a point of difference in tight market